The influence of free DTPA on the dose distribution of yttrium-90 radiolabelled antibodies

A. P. Farnsworth h., Andrew T M Vaughan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Yttrium-90 (90Y) bound to antibody via a DTPA group, was stable in-vitro until exposed to buffers below pH 5.4. It also exhibited minimal transchelation to transferring during serum incubation. In-vivo, two 90Y labelled antibodies of the same isotype but different specificities, showed similar distributions in tumour-bearing animals. Subsequent administration of a DTPA solution removed activity from liver and bone. This suggests that these tissues contain an environment in which a proportion of yttrium is released from the antibody, in a form suitable for removal with DTPA.

Original languageEnglish (US)
Pages (from-to)499-504
Number of pages6
JournalNuclear Medicine and Biology
Volume16
Issue number5
StatePublished - 1989
Externally publishedYes

Fingerprint

Yttrium
Pentetic Acid
Antibodies
Buffers
Bone and Bones
Liver
Serum
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

The influence of free DTPA on the dose distribution of yttrium-90 radiolabelled antibodies. / Farnsworth h., A. P.; Vaughan, Andrew T M.

In: Nuclear Medicine and Biology, Vol. 16, No. 5, 1989, p. 499-504.

Research output: Contribution to journalArticle

@article{0071d936040249778290b03d4771d4e0,
title = "The influence of free DTPA on the dose distribution of yttrium-90 radiolabelled antibodies",
abstract = "Yttrium-90 (90Y) bound to antibody via a DTPA group, was stable in-vitro until exposed to buffers below pH 5.4. It also exhibited minimal transchelation to transferring during serum incubation. In-vivo, two 90Y labelled antibodies of the same isotype but different specificities, showed similar distributions in tumour-bearing animals. Subsequent administration of a DTPA solution removed activity from liver and bone. This suggests that these tissues contain an environment in which a proportion of yttrium is released from the antibody, in a form suitable for removal with DTPA.",
author = "{Farnsworth h.}, {A. P.} and Vaughan, {Andrew T M}",
year = "1989",
language = "English (US)",
volume = "16",
pages = "499--504",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The influence of free DTPA on the dose distribution of yttrium-90 radiolabelled antibodies

AU - Farnsworth h., A. P.

AU - Vaughan, Andrew T M

PY - 1989

Y1 - 1989

N2 - Yttrium-90 (90Y) bound to antibody via a DTPA group, was stable in-vitro until exposed to buffers below pH 5.4. It also exhibited minimal transchelation to transferring during serum incubation. In-vivo, two 90Y labelled antibodies of the same isotype but different specificities, showed similar distributions in tumour-bearing animals. Subsequent administration of a DTPA solution removed activity from liver and bone. This suggests that these tissues contain an environment in which a proportion of yttrium is released from the antibody, in a form suitable for removal with DTPA.

AB - Yttrium-90 (90Y) bound to antibody via a DTPA group, was stable in-vitro until exposed to buffers below pH 5.4. It also exhibited minimal transchelation to transferring during serum incubation. In-vivo, two 90Y labelled antibodies of the same isotype but different specificities, showed similar distributions in tumour-bearing animals. Subsequent administration of a DTPA solution removed activity from liver and bone. This suggests that these tissues contain an environment in which a proportion of yttrium is released from the antibody, in a form suitable for removal with DTPA.

UR - http://www.scopus.com/inward/record.url?scp=0024365737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024365737&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0024365737

VL - 16

SP - 499

EP - 504

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 5

ER -